[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Roche Roche Roche posts on X about $rhhby, $rog, rog, faster the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::20815041/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XXX% - X Months XXXXXXXXX +2,212% - X Year XXXXXXXXX +9,078% ### Mentions: X [#](/creator/twitter::20815041/posts_active)  - X Week X no change - X Month XXX +280% - X Months XXX +248% - X Year XXX +268% ### Followers: XXXXXXX [#](/creator/twitter::20815041/followers)  - X Week XXXXXXX -XXXX% - X Month XXXXXXX -XXXX% - X Months XXXXXXX -XXXX% - X Year XXXXXXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::20815041/influencer_rank)  ### Social Influence **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XX% [stocks](/list/stocks) XX% **Social topic influence** [$rhhby](/topic/$rhhby) #5, [$rog](/topic/$rog) #2, [rog](/topic/rog) 20%, [faster](/topic/faster) 10%, [recommended](/topic/recommended) 10%, [the first](/topic/the-first) 10%, [global](/topic/global) 10%, [countries](/topic/countries) 10%, [education](/topic/education) 10%, [health](/topic/health) XX% **Top accounts mentioned or mentioned by** [@gap_foundation](/creator/undefined) [@paulbiogeek](/creator/undefined) [@pietjepsvpuk](/creator/undefined) [@ihwcouncil](/creator/undefined) [@phylferrell](/creator/undefined) [@biointron2012](/creator/undefined) [@novonordisk](/creator/undefined) [@mwcapital](/creator/undefined) [@cahr_acrss](/creator/undefined) [@satoritrade](/creator/undefined) [@sabcssanantonio](/creator/undefined) [@drrishabhonco](/creator/undefined) [@oppiindia](/creator/undefined) [@drmetinbasaran](/creator/undefined) [@auditor112017](/creator/undefined) [@arhdan9](/creator/undefined) [@investshanghai](/creator/undefined) [@swisscgny](/creator/undefined) [@paulmarganski](/creator/undefined) [@zinselmeyerb](/creator/undefined) **Top assets mentioned** [ROGin AI (ROG)](/topic/$rog) ### Top Social Posts Top posts by engagements in the last XX hours "Data show Roches innovations deliver improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies helping clinicians quickly identify heart attack and rule out non-cardiac causes: $RHHBY $ROG" [X Link](https://x.com/Roche/status/1972892919838158914) 2025-09-30T05:15Z 238.6K followers, 2609 engagements "#MEDIA - We are pleased the CHMP has recommended approval of our investigational medicine for adults with #lupusnephritis potentially helping to address the high unmet need for new treatment options if approved. $ROG $RHHBY" [X Link](https://x.com/Roche/status/1979142166388560044) 2025-10-17T11:07Z 238.6K followers, 1982 engagements "New test delivers results in half the time or less compared to current comparable solutions enabling faster patient management that can lower the risk of severe illness. $RHHBY $ROG" [X Link](https://x.com/Roche/status/1983417265237221501) 2025-10-29T06:15Z 238.6K followers, 2298 engagements "#MEDIA We are excited to share positive results from our phase III trial in systemic lupus erythematosus a potentially life-threatening autoimmune disease that affects more than three million people worldwide. 👉 $ROG $RHHBY" [X Link](https://x.com/Roche/status/1985275041995518267) 2025-11-03T09:17Z 238.6K followers, 2454 engagements "#MEDIA - Were pleased to share positive Phase III results for our investigational oral brain-penetrant medicine in primary progressive and relapsing forms of multiple sclerosis. $RHHBY $ROG" [X Link](https://x.com/Roche/status/1987770342996160751) 2025-11-10T06:32Z 238.6K followers, 2842 engagements "#MEDIA We are excited to share positive results from our phase III trial in children and young adults with idiopathic nephrotic syndrome the first global phase III study of a targeted therapy in this chronic disease. $ROG $RHHBY" [X Link](https://x.com/Roche/status/1983161107024855430) 2025-10-28T13:17Z 238.6K followers, 2095 engagements "Our #ChangingDiabetesInChildren initiative in collaboration with @novonordisk has spent XX years empowering T1D care in resource-limited countries through education & access. Now we're leveraging evidence-based insights to embed sustainable care into national health plans. Witness our impact: #diabetesinchildren #DiabetesCare #HealthEquity" [X Link](https://x.com/Roche/status/1994058636331458634) 2025-11-27T15:00Z 238.6K followers, 2151 engagements "Whooping cough (pertussis) results with PCR-level accuracy are now available at the point of care enabling primary care clinicians & emergency departments to act quickly treat appropriately prevent complications and control further spread. $RHHBY $ROG" [X Link](https://x.com/Roche/status/1995771269510201395) 2025-12-02T08:25Z 238.6K followers, 1852 engagements "As the needs and expectations of people living with haemophilia A continue to evolve Roches John Pasi explores how we can build on past breakthroughs to deliver more personalised care. Read the full story 👉 #HaemophiliaA #ASH2025 #PatientCentricity #InnovationInCare" [X Link](https://x.com/Roche/status/1997924106818191805) 2025-12-08T07:00Z 238.6K followers, 1639 engagements "#MEDIA - We are pleased our medicine for adults with active #lupusnephritis is approved in the EU providing those living with this potentially life-threatening disease with a much-needed new treatment option and potential new standard of care. $ROG $RHHBY" [X Link](https://x.com/Roche/status/1998327720976031844) 2025-12-09T09:43Z 238.6K followers, 1268 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Roche Roche
Roche posts on X about $rhhby, $rog, rog, faster the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XXX%
- X Months XXXXXXXXX +2,212%
- X Year XXXXXXXXX +9,078%
Mentions: X #
- X Week X no change
- X Month XXX +280%
- X Months XXX +248%
- X Year XXX +268%
Followers: XXXXXXX #
- X Week XXXXXXX -XXXX%
- X Month XXXXXXX -XXXX%
- X Months XXXXXXX -XXXX%
- X Year XXXXXXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence cryptocurrencies XX% stocks XX%
Social topic influence $rhhby #5, $rog #2, rog 20%, faster 10%, recommended 10%, the first 10%, global 10%, countries 10%, education 10%, health XX%
Top accounts mentioned or mentioned by @gap_foundation @paulbiogeek @pietjepsvpuk @ihwcouncil @phylferrell @biointron2012 @novonordisk @mwcapital @cahr_acrss @satoritrade @sabcssanantonio @drrishabhonco @oppiindia @drmetinbasaran @auditor112017 @arhdan9 @investshanghai @swisscgny @paulmarganski @zinselmeyerb
Top assets mentioned ROGin AI (ROG)
Top Social Posts
Top posts by engagements in the last XX hours
"Data show Roches innovations deliver improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies helping clinicians quickly identify heart attack and rule out non-cardiac causes: $RHHBY $ROG"
X Link 2025-09-30T05:15Z 238.6K followers, 2609 engagements
"#MEDIA - We are pleased the CHMP has recommended approval of our investigational medicine for adults with #lupusnephritis potentially helping to address the high unmet need for new treatment options if approved. $ROG $RHHBY"
X Link 2025-10-17T11:07Z 238.6K followers, 1982 engagements
"New test delivers results in half the time or less compared to current comparable solutions enabling faster patient management that can lower the risk of severe illness. $RHHBY $ROG"
X Link 2025-10-29T06:15Z 238.6K followers, 2298 engagements
"#MEDIA We are excited to share positive results from our phase III trial in systemic lupus erythematosus a potentially life-threatening autoimmune disease that affects more than three million people worldwide. 👉 $ROG $RHHBY"
X Link 2025-11-03T09:17Z 238.6K followers, 2454 engagements
"#MEDIA - Were pleased to share positive Phase III results for our investigational oral brain-penetrant medicine in primary progressive and relapsing forms of multiple sclerosis. $RHHBY $ROG"
X Link 2025-11-10T06:32Z 238.6K followers, 2842 engagements
"#MEDIA We are excited to share positive results from our phase III trial in children and young adults with idiopathic nephrotic syndrome the first global phase III study of a targeted therapy in this chronic disease. $ROG $RHHBY"
X Link 2025-10-28T13:17Z 238.6K followers, 2095 engagements
"Our #ChangingDiabetesInChildren initiative in collaboration with @novonordisk has spent XX years empowering T1D care in resource-limited countries through education & access. Now we're leveraging evidence-based insights to embed sustainable care into national health plans. Witness our impact: #diabetesinchildren #DiabetesCare #HealthEquity"
X Link 2025-11-27T15:00Z 238.6K followers, 2151 engagements
"Whooping cough (pertussis) results with PCR-level accuracy are now available at the point of care enabling primary care clinicians & emergency departments to act quickly treat appropriately prevent complications and control further spread. $RHHBY $ROG"
X Link 2025-12-02T08:25Z 238.6K followers, 1852 engagements
"As the needs and expectations of people living with haemophilia A continue to evolve Roches John Pasi explores how we can build on past breakthroughs to deliver more personalised care. Read the full story 👉 #HaemophiliaA #ASH2025 #PatientCentricity #InnovationInCare"
X Link 2025-12-08T07:00Z 238.6K followers, 1639 engagements
"#MEDIA - We are pleased our medicine for adults with active #lupusnephritis is approved in the EU providing those living with this potentially life-threatening disease with a much-needed new treatment option and potential new standard of care. $ROG $RHHBY"
X Link 2025-12-09T09:43Z 238.6K followers, 1268 engagements